Specialty Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064001
  • May 2021
  • Pharmaceuticals
  • 125 Pages
The Specialty Generics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Valeant Pharmaceuticals International, Inc.,, Novartis, Pfizer Inc.,, Turing Pharmaceuticals,, Teva Pharmaceutical Ltd.,, Mylan N.V.,, Akorn, Inc.,, Mallinckrodt, Lupin Pharmaceuticals, Sandoz, Sun Pharmaceuticals, Amneal Pharmaceuticals, Par Pharmaceuticals, Endo Pharmaceuticals, Actavis
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Specialty Generics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Specialty Generics market is expected to attain Pre COVID-19 levels by mid-2022.

Specialty Generics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Specialty Generics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Specialty Generics Market Competitive and Premeditated Analysis
In the Specialty Generics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Specialty Generics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Specialty Generics Market:
The Specialty Generics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Valeant Pharmaceuticals International, Inc.,, Novartis, Pfizer Inc.,, Turing Pharmaceuticals,, Teva Pharmaceutical Ltd.,, Mylan N.V.,, Akorn, Inc.,, Mallinckrodt, Lupin Pharmaceuticals, Sandoz, Sun Pharmaceuticals, Amneal Pharmaceuticals, Par Pharmaceuticals, Endo Pharmaceuticals, Actavis

The Specialty Generics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Specialty Generics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Specialty Generics market:
By Formulation type
oral
parenteral
topical
others
Therapeutic Application
oncology
inflammatory conditions
multiple sclerosis
hepatitis C
Distributional Channel
specialty pharmacy
retail pharmacy
hospital pharmacy
others

Regional Analysis of the Specialty Generics market:
The Specialty Generics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Specialty Generics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Specialty Generics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Specialty Generics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Specialty Generics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Specialty Generics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Specialty Generics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Specialty Generics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Specialty Generics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Specialty Generics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Valeant Pharmaceuticals International, Inc.,
  • Novartis
  • Pfizer Inc.,
  • Turing Pharmaceuticals,
  • Teva Pharmaceutical Ltd.,
  • Mylan N.V.,
  • Akorn, Inc.,
  • Mallinckrodt
  • Lupin Pharmaceuticals
  • Sandoz
  • Sun Pharmaceuticals
  • Amneal Pharmaceuticals
  • Par Pharmaceuticals
  • Endo Pharmaceuticals
  • Actavis
  • oral
  • parenteral
  • topical
  • others
  • oncology
  • inflammatory conditions
  • multiple sclerosis
  • hepatitis C
  • Distributional Channel
  • specialty pharmacy
  • retail pharmacy
  • hospital pharmacy
  • others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Specialty Generics Market Snapshot
          2.1.1. Global Specialty Generics Market By Formulation type,2019
               2.1.1.1.oral
               2.1.1.2.parenteral
               2.1.1.3.topical
               2.1.1.4.others
          2.1.2. Global Specialty Generics Market By Application,2019
               2.1.2.1.oncology
               2.1.2.2.inflammatory conditions
               2.1.2.3.multiple sclerosis
               2.1.2.4.hepatitis C
               2.1.2.5.Distributional Channel
               2.1.2.6.specialty pharmacy
               2.1.2.7.retail pharmacy
               2.1.2.8.hospital pharmacy
               2.1.2.9.others.
          2.1.3. Global Specialty Generics Market By End-use,2019
          2.1.4. Global Specialty Generics Market By Geography,2019

3. Global Specialty Generics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Formulation type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Formulation type, 2020
     4.2. Global Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028

5. Global Specialty Generics Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Specialty Generics Market Size (US$), By Application, 2018 – 2028

6. Global Specialty Generics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Specialty Generics Market Size (US$), By End-use, 2018 – 2028

7. Global Specialty Generics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Specialty Generics Market Analysis, 2018 – 2028 
          7.2.1. North America Specialty Generics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028
          7.2.3. North America Specialty Generics Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Specialty Generics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Specialty Generics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Specialty Generics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028
          7.3.3. Europe Specialty Generics Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Specialty Generics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Specialty Generics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Specialty Generics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028
          7.4.3. Asia Pacific Specialty Generics Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Specialty Generics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Specialty Generics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Specialty Generics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028
          7.5.3. Latin America Specialty Generics Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Specialty Generics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Specialty Generics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Specialty Generics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Specialty Generics Market Size (US$), By Formulation type, 2018 – 2028
          7.6.3. MEA Specialty Generics Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Specialty Generics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Specialty Generics Providers
        8.4.1 Valeant Pharmaceuticals International, Inc.,
                8.4.1.1 Business Description
                8.4.1.2 Valeant Pharmaceuticals International, Inc., Geographic Operations
                8.4.1.3 Valeant Pharmaceuticals International, Inc., Financial Information
                8.4.1.4 Valeant Pharmaceuticals International, Inc., Product Positions/Portfolio
                8.4.1.5 Valeant Pharmaceuticals International, Inc., Key Developments
        8.4.2 Novartis
                8.4.2.1 Business Description
                8.4.2.2 Novartis Geographic Operations
                8.4.2.3 Novartis Financial Information
                8.4.2.4 Novartis Product Positions/Portfolio
                8.4.2.5 Novartis Key Developments
        8.4.3 Pfizer Inc.,
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Inc., Geographic Operations
                8.4.3.3 Pfizer Inc., Financial Information
                8.4.3.4 Pfizer Inc., Product Positions/Portfolio
                8.4.3.5 Pfizer Inc., Key Developments
        8.4.4 Turing Pharmaceuticals,
                8.4.4.1 Business Description
                8.4.4.2 Turing Pharmaceuticals, Geographic Operations
                8.4.4.3 Turing Pharmaceuticals, Financial Information
                8.4.4.4 Turing Pharmaceuticals, Product Positions/Portfolio
                8.4.4.5 Turing Pharmaceuticals, Key Developments
        8.4.5 Teva Pharmaceutical Ltd.,
                8.4.5.1 Business Description
                8.4.5.2 Teva Pharmaceutical Ltd., Geographic Operations
                8.4.5.3 Teva Pharmaceutical Ltd., Financial Information
                8.4.5.4 Teva Pharmaceutical Ltd., Product Positions/Portfolio
                8.4.5.5 Teva Pharmaceutical Ltd., Key Developments
        8.4.6 Mylan N.V.,
                8.4.6.1 Business Description
                8.4.6.2 Mylan N.V., Geographic Operations
                8.4.6.3 Mylan N.V., Financial Information
                8.4.6.4 Mylan N.V., Product Positions/Portfolio
                8.4.6.5 Mylan N.V., Key Developments
        8.4.7 Akorn, Inc.,
                8.4.7.1 Business Description
                8.4.7.2 Akorn, Inc., Geographic Operations
                8.4.7.3 Akorn, Inc., Financial Information
                8.4.7.4 Akorn, Inc., Product Positions/Portfolio
                8.4.7.5 Akorn, Inc., Key Developments
        8.4.8 Mallinckrodt
                8.4.8.1 Business Description
                8.4.8.2 Mallinckrodt Geographic Operations
                8.4.8.3 Mallinckrodt Financial Information
                8.4.8.4 Mallinckrodt Product Positions/Portfolio
                8.4.8.5 Mallinckrodt Key Developments
        8.4.9 Lupin Pharmaceuticals
                8.4.9.1 Business Description
                8.4.9.2 Lupin Pharmaceuticals Geographic Operations
                8.4.9.3 Lupin Pharmaceuticals Financial Information
                8.4.9.4 Lupin Pharmaceuticals Product Positions/Portfolio
                8.4.9.5 Lupin Pharmaceuticals Key Developments
        8.4.10 Sandoz
                8.4.10.1 Business Description
                8.4.10.2 Sandoz Geographic Operations
                8.4.10.3 Sandoz Financial Information
                8.4.10.4 Sandoz Product Positions/Portfolio
                8.4.10.5 Sandoz Key Developments
        8.4.11 Sun Pharmaceuticals
                8.4.11.1 Business Description
                8.4.11.2 Sun Pharmaceuticals Geographic Operations
                8.4.11.3 Sun Pharmaceuticals Financial Information
                8.4.11.4 Sun Pharmaceuticals Product Positions/Portfolio
                8.4.11.5 Sun Pharmaceuticals Key Developments
        8.4.12 Amneal Pharmaceuticals
                8.4.12.1 Business Description
                8.4.12.2 Amneal Pharmaceuticals Geographic Operations
                8.4.12.3 Amneal Pharmaceuticals Financial Information
                8.4.12.4 Amneal Pharmaceuticals Product Positions/Portfolio
                8.4.12.5 Amneal Pharmaceuticals Key Developments
        8.4.13 Par Pharmaceuticals
                8.4.13.1 Business Description
                8.4.13.2 Par Pharmaceuticals Geographic Operations
                8.4.13.3 Par Pharmaceuticals Financial Information
                8.4.13.4 Par Pharmaceuticals Product Positions/Portfolio
                8.4.13.5 Par Pharmaceuticals Key Developments
        8.4.14 Endo Pharmaceuticals
                8.4.14.1 Business Description
                8.4.14.2 Endo Pharmaceuticals Geographic Operations
                8.4.14.3 Endo Pharmaceuticals Financial Information
                8.4.14.4 Endo Pharmaceuticals Product Positions/Portfolio
                8.4.14.5 Endo Pharmaceuticals Key Developments
        8.4.15 Actavis
                8.4.15.1 Business Description
                8.4.15.2 Actavis Geographic Operations
                8.4.15.3 Actavis Financial Information
                8.4.15.4 Actavis Product Positions/Portfolio
                8.4.15.5 Actavis Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Specialty Generics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Specialty Generics Market Revenue, By Formulation type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Specialty Generics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Specialty Generics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Specialty Generics Market Revenue, By Formulation type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Specialty Generics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Specialty Generics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Specialty Generics Market Revenue, By Formulation type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Specialty Generics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Specialty Generics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Specialty Generics Market Revenue, By Formulation type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Specialty Generics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Specialty Generics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Specialty Generics Market Revenue, By Formulation type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Specialty Generics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Specialty Generics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Specialty Generics: Market Segmentation 
FIG. 2 Global Specialty Generics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Specialty Generics Market, By Formulation type, 2019 (US$ Mn) 
FIG. 5 Global Specialty Generics Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Specialty Generics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Specialty Generics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Specialty Generics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Specialty Generics Providers, 2019
FIG. 11 Global Specialty Generics Market Revenue Contribution, By Formulation type, 2019 & 2028 (Value %) 
FIG. 12 Global Specialty Generics Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Specialty Generics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Specialty Generics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Specialty Generics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Specialty Generics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Specialty Generics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Specialty Generics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Specialty Generics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Specialty Generics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Specialty Generics Market Value, By Segment1, 2018 – 2028
TABLE  North America Specialty Generics Market Value, By Segment2, 2018 – 2028
TABLE  North America Specialty Generics Market Value, By Country, 2018 – 2028
TABLE  Europe Specialty Generics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Specialty Generics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Specialty Generics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Specialty Generics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Specialty Generics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Specialty Generics Market Value, By Country, 2018 – 2028
TABLE  Latin America Specialty Generics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Specialty Generics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Specialty Generics Market Value, By Country, 2018 – 2028
TABLE  MEA Specialty Generics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Specialty Generics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Specialty Generics Market Value, By Country, 2018 – 2028
TABLE  Valeant Pharmaceuticals International, Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Turing Pharmaceuticals,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Ltd.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Akorn, Inc.,: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mallinckrodt: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lupin Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sandoz: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amneal Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Par Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Endo Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Actavis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Specialty Generics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Specialty Generics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Specialty Generics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Specialty Generics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Specialty Generics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Specialty Generics Providers, 2016
FIG.  Global Specialty Generics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global parenteral Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global topical Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Specialty Generics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global inflammatory conditions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global multiple sclerosis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global hepatitis C Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Distributional Channel Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global specialty pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global retail pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global hospital pharmacy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global others. Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Specialty Generics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Specialty Generics Market Value, 2018 – 2028, (US$ Mn)